We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Fevertree Drinks Plc | FEVR | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1,080.00 | 1,073.00 | 1,098.00 | 1,093.00 | 1,091.00 |
Industry Sector |
---|
BEVERAGES |
Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
---|---|---|---|---|---|---|
12/09/2023 | Interim | GBP | 0.0574 | 28/09/2023 | 29/09/2023 | 20/10/2023 |
22/03/2023 | Final | GBP | 0.1068 | 20/04/2023 | 21/04/2023 | 02/06/2023 |
13/09/2022 | Interim | GBP | 0.0563 | 29/09/2022 | 30/09/2022 | 21/10/2022 |
16/03/2022 | Final | GBP | 0.1047 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
16/03/2022 | Special | GBP | 0.429 | 07/04/2022 | 08/04/2022 | 27/05/2022 |
15/09/2021 | Interim | GBP | 0.0552 | 30/09/2021 | 01/10/2021 | 22/10/2021 |
18/03/2021 | Final | GBP | 0.1027 | 08/04/2021 | 09/04/2021 | 28/05/2021 |
08/09/2020 | Interim | GBP | 0.0541 | 24/09/2020 | 25/09/2020 | 16/10/2020 |
22/04/2020 | Final | GBP | 0.0988 | 14/05/2020 | 15/05/2020 | 12/06/2020 |
23/07/2019 | Interim | GBP | 0.052 | 08/08/2019 | 09/08/2019 | 06/09/2019 |
Top Posts |
---|
Posted at 27/1/2024 21:08 by apad In these times of highly fluctuating costs, how many years of revenue buys the company is a good metric.FEVR is about 3.5 years. Given the potential for growth this is not so expensive. Amusingly Bioventix is 19 years 😊 apad |
Posted at 16/1/2024 14:14 by philanderer Liberum upgrades Fevertree on recovery prospectsLiberum has upgraded premium mixer maker Fevertree (FEVR) as a trough in margins indicates a recovery in this year and next. Analyst Anubhav Malhotra upgraded his recommendation from ‘hold’ to ‘buy’ and increased the target price from £12.00 to £13.00 on the stock, which was trading at £9.98 on Monday. Malhotra said the company’s strategy ‘has been focused on market share gains against a backdrop of significant input cost inflation over the last two years’. Margins have ‘troughed̵ ‘We see scope for a greater recovery in 2024 and 2025 than consensus expects and therefore move to ‘buy’ ‘Despite the [fact] that ‘bad news’ might not be over, the valuation at 17x 12 months forward consensus embedded value/Ebitda and 28x price/earnings – 40-50% below historic average – looks reasonable.’ Mahotra said that for investors ‘wanting to build a position, now is the time considering the low average daily volume of 265,000’. citywire.com |
Posted at 28/10/2023 03:50 by bones698 Watched from the sidelines for some time but now look a critical point unfortunately not for the better . Costa and wage increases are hurting low margin businesses .cost of living and inflation will also hit companies like this hard with people choosing cheaper options .What you need to see are forward thinking changes to the business . Supply of own ingredients , security of co2 supply given what happened recently . Energy efficiency etc etc failure to adapt and plan will hurt companies like fevr unfortunately many are to bloated with managers who just plod along and cant adapt or are willing to change . A tough period lies ahead it will be interesting to see where this is In a year or two from here . Good luck |
Posted at 19/10/2023 07:45 by castleford tiger bullplease remain polite........you asked a question. I dont get FEVR but i spend a million quid a year with them........ Tiger |
Posted at 18/10/2023 12:19 by bulltradept FFS, we get it you don't get Fevr! |
Posted at 12/9/2023 13:32 by kalai1 Fevertree Drinks plc posted Interims for the HY ended 30th June this morning. The Group recorded revenue growth of 9% year-on-year to £175.6m, with a standout performance in the US of +40% growth which is now the Group's largest region by revenue contribution. Profits were held back a little driven by product cost headwinds, partially offset by efficiency projects, adjusted EBITDA dropped 54% to £10.2m. EPS was down more dramatically by 90% to 1.2p. Valuation remains the main cloud for the investment case with forward PE ratio at 47.9x looking a little prohibitive. The share has a market cap of over £1.5b on statutory net profit of under £25m. There is lots of growth here, but FEVR remains a share to monitor at current prices......from WealthOracle |
Posted at 12/9/2023 07:54 by gswredland Agree John.This often happens with FEVR |
Posted at 27/4/2023 10:21 by trident5 "No JohnDoe - Bloomberg reported yesterday that Goldman Sachs and JPMorgan were working with a possible suitor for FEVR. So pretty solid rumour that FEVR has bid interest."Got a link to back the solid rumour up? |
Posted at 04/4/2023 12:53 by apad Nice one, aiming.I was in an hotel in Buxton. FEVR the only tonic on offer. Five quid for a double Tanqueray and FEVR tonic. In Jersey (UK) folks are still going to the pubs and paying ten quid for a large glass of wine! There seems to be plenty of alternative 'posh' tonics in the UK supermarkets but they don't seem to have the cachet of FEVR. I guess FEVR management has the pricing skills to keep their stock moving. Even if glass bottles are expensive! I think I'll match my FEVR holding with some CPC shares. It seems that the alcohol culture is not a 'consumer discretionary'. 😊 Keep the insider information coming Castleford Tiger. Much appreciated. apad |
Posted at 30/9/2019 22:36 by trying2getrichquick Fevertree DrinksMarket Cap - UK£2.8b Last Updated - 2019/09/29 22:01 UTC Executive Summary Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. Snowflake Fundamentals Flawless balance sheet with solid track record. Share Price & News How has Fevertree Drinks's share price performed over time and what events caused price changes? Latest Share Price and Events Market Performance 7 Day Return 0.6% FEVR 2.1% GB Beverage 0.2% GB Market 1 Year Return -32.9% FEVR 15.7% GB Beverage -1.8% GB Market Return vs Industry: FEVR underperformed the UK Beverage industry which returned 15.7% over the past year. Return vs Market: FEVR underperformed the UK Market which returned -1.8% over the past year. Share holder returns FEVR Industry Market 7 Day 0.6% 2.1% 0.2% 30 Day 7.1% -4.7% 3.3% 90 Day 4.8% -3.0% -0.4% 1 Year -32.5%-32.9% 18.9%15.7% 2.8%-1.8% 3 Year 153.1%149.6% 62.1%50.3% 21.3%6.8% 5 Year n/a 112.2%85.4% 36.2%7.3% Price Volatility Vs. Market Valuation Is Fevertree Drinks undervalued based on future cash flows and its price relative to the stock market? Analysis Checks 0/6 44.15x Price to Earnings (PE) ratio Intrinsic Value Based on Future Cash Flows 25.8%Overvalued Current PriceUK£24.21F Undervalued: FEVR (£24.21) is trading above our estimate of fair value (£19.25) Significantly Undervalued: FEVR is trading above our estimate of fair value. Price Based on Earnings }}}0x10x20x30x40x50x PE Ratio company 44.1x industry 25.2x market 16x PE vs Industry: FEVR is poor value based on its PE Ratio (44.1x) compared to the Beverage industry average (25.2x). PE vs Market: FEVR is poor value based on its PE Ratio (44.1x) compared to the UK market (16x). Price Based on Expected Growth }0x1x2x3x4x PEG Ratio company 4.2x Low PEG Ratio: FEVR is poor value based on its PEG Ratio (4.2x) Price Based on Value of Assets }}}0x5x10x15x20x PB Ratio company 14x industry 3.6x market 1.5x PB vs Industry: FEVR is overvalued based on its PB Ratio (14x) compared to the GB Beverage industry average (3.6x). Next Steps Explore potentially undervalued companies in the Food, Beverage & Tobacco industry. Future Growth How is Fevertree Drinks expected to perform in the next 1 to 3 years based on estimates from 11 analysts? Analysis Checks 3/6 10.5% Forecasted annual earnings growth Earnings and Revenue Growth Estimates GBPRevenueCash FlowEarnings Growth Rates201720182019202 Future Annual Growth Analysis company10.5%industry market12.5% forecast annual earnings growth company12.3%industry market4.1% forecast annual revenue growth Earnings vs Savings Rate: FEVR's forecast earnings growth (10.5% per year) is above the savings rate (1.2%). Earnings vs Market: FEVR's earnings (10.5% per year) are forecast to grow slower than the UK market (12.5% per year). High Growth Earnings: FEVR's earnings are forecast to grow, but not significantly. Revenue vs Market: FEVR's revenue (12.3% per year) is forecast to grow faster than the UK market (4.1% per year). High Growth Revenue: FEVR's revenue (12.3% per year) is forecast to grow slower than 20% per year. Earnings per Share Growth Estimates GBP 20172018201920202021 Historical Range of past estimates Analyst's estimate Range of estimates Future Return on Equity }}0%10%20%30%40% Future ROE (3yrs) company 26.4% industry 18.1% High Future ROE: FEVR's Return on Equity is forecast to be high in 3 years time (26.4%) Past Performance How has Fevertree Drinks performed over the past 5 years? Analysis Checks 5/6 48.6% Historical annual earnings growth Earnings and Revenue History GBPRevenueCash FlowEarningsOperatin Growth Rate2013201420152016 Past Earnings Growth Analysis company48.6%industry market13.4% past 5 years annual earnings growth company21.1%industry market6.8% last 1 year earnings growth Earnings Trend: FEVR's earnings have grown significantly by 48.6% per year over the past 5 years. Accelerating Growth: FEVR's earnings growth over the past year (21.1%) is below its 5-year average (48.6% per year). Earnings vs Industry: FEVR earnings growth over the past year (21.1%) exceeded the United Kingdom of Great Britain and Northern Ireland industry 4.6%. Return on Equity }}0%10%20%30%40% ROE company 31.7% industry 18.1% High ROE: FEVR's Return on Equity (31.7%) is considered high. Return on Assets }}0%2%4%6%8%10% ROA company 26.5% industry 8.5% ROA vs Industry: FEVR has a higher Return on Assets than the Beverage industry average last year. Return on Capital Employed }}0%10%20%30% ROCE last year 38.4% 3 years ago 27.6% ROCE Improving: FEVR has significantly improved its Return on Capital Employed over the past 3 years. Financial Health How is Fevertree Drinks's financial position? Analysis Checks 5/6 Financial Position Analysis GBP 20132014201520162017 GBPShort termLong termNet worth LiabilitiesAssets Short Term Liabilities: FEVR's short term assets (£189.9M) exceeds its short term liabilities (£36.7M) Long Term Liabilities: FEVR's short term assets (£189.9M) exceeds its long term liabilities (£1.5M) Debt to Equity History and Analysis GBPDebtNet worth (Equity)Cash 20132014201520162017 Debt Level: FEVR is debt free. Reducing Debt: FEVR currently has no debt however we can't compare to 5 years ago as we have no data for that period. Debt Coverage: FEVR has no debt, therefore it does not need to be covered by operating cash flow. Interest Coverage: FEVR has no debt, therefore coverage of interest payments is not a concern. Balance Sheet Assets Cash + Short termInvestmentsRecei Liabilities + Equity EquityDebtAccountsPa Inventory Level: FEVR has a low level of unsold assets or inventory. Debt Coverage by Assets: Insufficient data to determine if FEVR's debt is covered by short term assets. Dividend What is Fevertree Drinks's current dividend yield, its reliability and sustainability? Analysis Checks 0/6 0.80% Expected Dividend Yield Dividend Yield and Payments Analysis DPSFEVR DPSFEVR YieldBeverageMarket 20162017201820192020 2.1% 1.4% 0.1% 0.6% Notable Dividend: FEVR's dividend (0.6%%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.97%%). High Dividend: FEVR's dividend (0.6%) is low compared to the top 25% of dividend payers in the UK market (5.47%). Stable Dividend: FEVR is not paying a notable dividend for the UK market, therefore no need to check if payments are stable. Growing Dividend: FEVR is not paying a notable dividend for the UK market, therefore no need to check if payments are increasing. Current Payout to Shareholders 28%Now Retained byFevertree Drin…Paid to you Dividend Coverage: FEVR is not paying a notable dividend for . Future Payout to Shareholders 30%+3 yrs Retained byFevertree Drin…Paid to you Future Dividend Coverage: No need to calculate the sustainability of FEVR's dividend in 3 years as they are not forecast to pay a notable one for the UK market. Management What is the CEO of Fevertree Drinks's salary, the management and board of directors tenure and is there insider trading? 3.3yrs Average board tenure CEO Tim Warrillow (44yo) 0yrs Tenure UK£3,981,000 Compensation Mr. Timothy Daniel Gray Warrillow, also known as Tim, is a Co-Founder, Chief Executive Officer and Executive Director at Fevertree Drinks Plc. Mr. Warrillow joined a London-based advertising and branding a ... CEO Compensation Analysis GBPTotal CompensationSalaryFe 20142015201620172018 Compensation vs. Market: Tim's total compensation ($USD4.90M) is about average for companies of similar size in the UK market ($USD2.26M). Compensation vs Earnings: Tim's compensation has increased by more than 20% in the past year. Board Age and Tenure 3.3yrs Average Tenure 55yo Average Age Experienced Board: FEVR's board of directors are considered experienced (3.3 years average tenure). Insider Trading SOLDBOUGHTSold by companiesSold by individualsBought by companiesBought by individuals0-3 months3-6 months6-9 months9-12 months Insider Buying: FEVR insiders have bought more shares than they have sold in the past 3 months. Recent Insider Transactions AIM:FEVR Recent Insider Transactions by Companies or IndividualsDate Value Name Entity Role Shares Max Price 16 Aug 19 BuyUK£43,320 Jeff Popkin Individual 2,000 UK£21.66 25 Jul 19 BuyUK£289,561 Kevin Havelock Individual 13,298 UK£21.99 07 Dec 18 BuyUK£67,843 Jeff Popkin Individual 2,933 UK£23.17 11 Oct 18 BuyUK£167,946 Kevin Havelock Individual 5,727 UK£29.55 Ownership Breakdown General PublicIndividual InsidersPrivate CompaniesInstitution Institutions Private Companies Individual Insiders General Public Management Team Charles Rolls (62yo) Co-Founder & Non-Executive Deputy Chairman Tenure: 0yrs Tim Warrillow (44yo) Co-Founder Tenure: 0yrs Compensation: UK£3.98m Andy Branchflower (40yo) Finance Director Tenure: 4.9yrs Compensation: UK£1.92m Saskia Stoop (35yo) Head of Marketing Tenure: 0yrs Claire Huntingford (38yo) Head of Supply Chain Tenure: 0yrs Charles Gibb Global Strategy Director & CEO of North American Tenure: 1.8yrs Oliver Winters Communications & IR Director Tenure: 0yrs Board Members Bill Ronald (63yo) Non-Executive Chairman Tenure: 6.3yrs Compensation: UK£125.00k Coline McConville (55yo) Independent Non-Executive Director Tenure: 4.8yrs Compensation: UK£58.00k Jeff Popkin (54yo) Independent Non Executive Director Tenure: 1.7yrs Compensation: UK£46.00k Kevin Havelock (61yo) Independent Non-executive Director Tenure: 1.7yrs Compensation: UK£46.00k Domenic De Lorenzo (55yo) Independent Non-Executive Director Tenure: 1.3yrs Compensation: UK£30.00k Charles Rolls (62yo) Co-Founder & Non-Executive Deputy Chairman Tenure: 0yrs Tim Warrillow (44yo) Co-Founder Tenure: 0yrs Compensation: UK£3.98m Andy Branchflower (40yo) Finance Director Tenure: 4.9yrs Compensation: UK£1.92m Company Information Fevertree Drinks Plc's company bio, employee growth, exchange listings and data sources Key Information Fevertree Drinks Plc logo Name: Fevertree Drinks Plc Ticker: FEVR Exchange: AIM Founded: 2013 Industry: Soft Drinks Sector: Food, Beverage & Tobacco Market Cap: UK£2.811b Shares outstanding: 116.13m Website: hxxps://www.fever-tr Fevertree Drinks Plc 186 -188 Shepherds Bush Road London Greater London W6 7NL United Kingdom Listings Ticker Exchange Primary Security Security Type Country Currency Listed on FEVR AIM (London Stock Exchange AIM Market) Yes Ordinary Shares GB GBP Nov 2014 FQVT.F OTCPK (Pink Sheets LLC) Yes Ordinary Shares US USD Nov 2014 FV8 DB (Deutsche Boerse AG) Yes Ordinary Shares DE EUR Nov 2014 Biography Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company’s products include Indian ... Company Analysis and Financial Data Status All financial data provided by Standard & Poor's Capital IQ.Data Last Updated (UTC time) Company Analysis 2019/09/29 22:01 End of Day Share Price 2019/09/27 00:00 Earnings 2019/06/30 Annual Earnings 2018/12/31 Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Credit: Simply Wall Street |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions